TB-500 vs BPC-157: What Each Peptide Is, How They Differ, and How to Vet a COA Before You Buy

TB-500 and BPC-157 are two of the most-searched research peptides, and they are constantly confused for one another because they show up together in “recovery stack” discussions and combination products. They are not the same thing. BPC-157 is a synthetic 15-amino-acid pentadecapeptide based on a partial sequence found in human gastric juice; TB-500 is a synthetic fragment of Thymosin Beta-4, a naturally occurring 43-amino-acid actin-sequestering protein. Different sequence, different length, different studied mechanism in animal models. But once you strip away the mechanism talk, the buyer’s real question about either vial is identical and simpler: does it ship with an independently verifiable third-party COA (HPLC plus mass-spec) that you can read BEFORE you pay?

Published 2026 - For research use only (RUO). Nothing here is medical advice, a dosing protocol, or a human-use recommendation. Any concentration math is standard laboratory reconstitution arithmetic for handling a research sample, not an instruction to administer anything.

In a hurry? Jump to how Pepora scores on the checklist →

---

What each one actually is

The single biggest mistake in the “TB-500 vs BPC-157” search is treating them as two brands of the same thing. They are chemically unrelated.

BPC-157 (sometimes written as the stable gastric pentadecapeptide, or under the research code PL 14736) is a synthetic peptide of 15 amino acids. Its sequence corresponds to a partial fragment identified in human gastric juice. In the literature it is studied as a single defined pentadecapeptide.

TB-500 is the common research-market name for a synthetic peptide based on Thymosin Beta-4 (TB4). Thymosin Beta-4 itself is a naturally occurring 43-amino-acid protein described as the major actin-sequestering molecule in eukaryotic cells [1]. TB-500 material sold for research is a synthetic fragment/analog built around the active region of that parent protein. An important consequence for COA reading: because “TB-500” and “Thymosin Beta-4” are used loosely across vendors, you want the certificate to state exactly which sequence was tested and to confirm its identity by mass spectrometry, not just report a purity percentage against an unnamed target.

So: one is a short 15-mer from a gastric sequence, the other is a fragment of a 43-mer actin-regulating protein. Same shelf, same “recovery” folklore, completely different molecules.

How they work, in research terms

These are distinct mechanisms characterized in animal and cell-culture models. None of this is an outcome demonstrated in humans, and none of it is a benefit claim.

BPC-157. In tendon-fibroblast research, BPC-157 was reported to upregulate the growth hormone receptor at both mRNA and protein levels in a dose- and time-dependent manner, which the authors framed as a way it could potentiate proliferation-related signaling in tendon cells [2]. Broader animal work associates it with angiogenic and collagen-related pathways in models of ligament and muscle-tendon injury [3]. The through-line in the research is fibroblast activity and vascular/collagen pathways.

TB-500 / Thymosin Beta-4. The parent protein’s defining property in the literature is actin sequestration: Thymosin Beta-4 binds monomeric G-actin roughly 1:1 and thereby helps regulate the pool of actin available for cytoskeletal assembly, which is central to cell migration and lamellipodia formation [1]. Separate work maps a short actin-binding motif within the peptide to its angiogenic activity in endothelial migration and vessel-sprouting assays [4]. The through-line here is actin dynamics and cell migration.

That difference - fibroblast/collagen signaling versus actin regulation and migration - is exactly why researchers describe the two as complementary and why combination formats (the Wolverine-style blend) exist. Complementary study design is not proof of any additive effect in people.

If you want the full single-compound write-ups, see /bpc-157-research-guide and /tb-500-research-guide (companion pieces in this cluster).

What the research actually shows

Read the citations for what they are: animal-model and in-vitro studies, plus reviews of that literature.

• Thymosin Beta-4 is characterized as an actin-sequestering protein that “moonlights” in tissue repair, binding G-actin and influencing migration and repair processes in injury models [1].
• A short actin-binding site within Thymosin Beta-4 was shown to drive angiogenic activity in endothelial-cell migration and aortic-sprouting assays at low nanomolar concentrations [4].
• BPC-157 upregulated growth hormone receptor expression in cultured tendon fibroblasts, dose- and time-dependently [2].
• BPC-157 was reported to improve ligament healing outcomes in a rat model [3].
• A 2025-era scoping review of Thymosin Beta-4 and TB-500 catalogs the tissue-healing and musculoskeletal-repair literature and, like most reviews in this space, notes that the bulk of evidence is preclinical [5].

What the research does not show: any approved human indication, any established human dose, or any demonstrated clinical benefit for either peptide. Anyone presenting a “results” table for human use is overstating the evidence.

Regulatory / legal status

Neither BPC-157 nor TB-500 is an approved drug for human use. Vials of either sold in this market are research-use-only (RUO) chemicals - not medicines, not supplements, and not cleared for human or veterinary administration. That RUO status is why a real, verifiable COA matters more here than in almost any other product category: there is no regulator checking the vial’s identity or purity for you, so the certificate is the only trust signal you have.

On sport: both peptides are relevant to anti-doping context (Thymosin Beta-4 / TB-500 in particular has been discussed under WADA’s prohibited-substance framework), which is a reason competing athletes treat them as off-limits - stated here only for accuracy, not as usage guidance. For the broader legality picture on this class, /is-bpc-157-legal-2026 covers it in depth; this page does not duplicate that scope.

Lab-prep reconstitution math

This is where the “dosage chart” search intent actually belongs - as reconstitution arithmetic for handling a research sample, not a dosing instruction. The math is identical for both peptides; only the labeled mass changes.

Reconstitution is just mass divided by volume. You add a measured volume of bacteriostatic water to the lyophilized vial and read off the resulting concentration. The critical rule: trust the mass on the COA, not the number printed on the cap. A cap that says “10 mg” means nothing if the certificate reports a different recovered mass or a purity that changes the actual peptide content.

Vial mass (per COA)	Bacteriostatic water added	Concentration	Per 0.1 mL aliquot
5 mg	2 mL	2.5 mg/mL	0.25 mg
5 mg	5 mL	1.0 mg/mL	0.10 mg
10 mg	2 mL	5.0 mg/mL	0.50 mg
10 mg	5 mL	2.0 mg/mL	0.20 mg

Read this as concentration handling for a labeled research sample, not as any recommendation to administer material. The word is “aliquot,” never “dose.” For the mechanics of bacteriostatic water and mixing, see /bacteriostatic-water-reconstitution-guide.

One peptide-specific note: because TB-500 material varies by vendor between full-length-style and fragment forms, the labeled mass and the COA-confirmed identity are what your arithmetic should be based on - not the product name.

How to vet a vendor: checkable criteria

This is the part that actually decides a purchase, and it is the same test for both peptides. Ignore the mechanism marketing and score the certificate on signals you can independently check.

Verification signal	What “pass” looks like	Why it matters
Named third-party lab	An independent lab is named (e.g. Freedom Diagnostics), not “in-house QC”	A vendor grading its own homework is not verification
Independently verifiable report	An accession/batch ID you can look up on the lab’s own site	Lets you confirm the COA wasn’t edited or reused
Report visible pre-purchase	You can read the full COA before checkout	Post-purchase “COA on request” is a red flag
HPLC + mass spec	Both a purity % (HPLC/UV) and an identity confirmation (MS)	HPLC alone shows purity, not that it’s the right molecule
Purity tied to a trace	The % is attached to a specific batch/accession, not a generic claim	An untraceable number is marketing, not data

If a listing for either TB-500 or BPC-157 fails any row, treat its purity figure as an unverified claim. More red flags are catalogued at /peptide-vendor-red-flags, and community-sourced vendor discussion is covered at /best-peptide-sources-reddit-2026.

How Pepora scores

Being an affiliate, here is the honest scorecard rather than a flattering one - and the two peptides in this comparison land in two different places.

TB-500 / Thymosin Beta-4 - strong pass. Pepora’s TB-500 SKU carries a Freedom Diagnostics third-party COA reporting 99.699% purity under search code Pepo2603130123, verifiable by search code at FreedomDiagnosticsTesting.com. Freedom is a US lab running HPLC + mass spec, so this SKU clears every row of the checklist above: named third-party lab, verifiable accession, HPLC purity, mass-spec identity, and a purity number tied to a specific trace.

BPC-157 - honest caveat. At time of writing, BPC-157 is not one of the SKUs covered by a Freedom Diagnostics third-party report. Freedom coverage currently spans four SKUs - GHK-Cu (99.98%, Pepo2603130126), Tesamorelin (99.348%, Pepo2603130125), TB-500 / Thymosin Beta-4 (99.699%, Pepo2603130123), and GLP-3 RT (99.67%, Pepo2603130122) - and testing is being expanded across the catalog. So do not assume the BPC-157 vial carries a Freedom COA it does not currently have. If third-party verification is your hard requirement, the TB-500 SKU meets it today and BPC-157 does not yet; check the specific product page before you pay.

That split is the whole point of buying on verifiable criteria instead of brand trust: the same store can be a clear pass on one SKU and a “not yet verified” on another, and only the COA tells you which.

The disclosed pick

FAQ

Is TB-500 the same as BPC-157? No. They are structurally unrelated peptides. BPC-157 is a synthetic 15-amino-acid pentadecapeptide derived from a sequence in human gastric juice. TB-500 is a synthetic fragment based on Thymosin Beta-4, a naturally occurring 43-amino-acid actin-sequestering protein. Different sequence, different length, different studied mechanism. They are frequently studied side by side, but they are not interchangeable and not the same molecule.

Why are TB-500 and BPC-157 so often researched together? In the research-peptide world the two are commonly paired because their studied mechanisms in animal models are described as complementary rather than overlapping: BPC-157 work centers on fibroblast and angiogenic pathways, while Thymosin Beta-4 work centers on actin regulation and cell migration. That pairing is the basis for combination products such as the Wolverine blend. Pairing them in a study design is not evidence of any human benefit, and this site makes no such claim.

What is the core mechanistic difference between the two? In published animal and cell-culture research, BPC-157 has been associated with upregulation of the growth hormone receptor in tendon fibroblasts and with angiogenic and collagen-related pathways. Thymosin Beta-4 (the parent of TB-500) is characterized in the literature as the major actin-sequestering molecule in cells, binding monomeric G-actin 1:1 and influencing cell migration. These are distinct mechanisms studied in models, not proven outcomes in people.

Is there a TB-500 vs BPC-157 dosage chart I should follow? There is no human dosing guidance on this page, and you should treat any “dosage chart” you see elsewhere with caution. Both are research-use-only materials with no approved human indication. What is legitimate to discuss is reconstitution arithmetic: how much bacteriostatic water you add to a lyophilized vial and what concentration per aliquot that yields for handling a research sample. That is lab math, covered above, not a dosing protocol.

Does Pepora carry a third-party COA for TB-500 and BPC-157? Pepora’s TB-500 / Thymosin Beta-4 SKU carries a Freedom Diagnostics third-party COA reporting 99.699% purity (search code Pepo2603130123), verifiable by search code at FreedomDiagnosticsTesting.com. BPC-157 is a different case: at time of writing it is not one of the handful of SKUs covered by a Freedom third-party report. Freedom coverage currently spans four SKUs and is being expanded across the catalog, so verify the specific product page before you pay.

How do I verify a COA for either peptide before buying? Confirm the report names an independent third-party lab (not the vendor’s in-house bench), that it lists both HPLC purity and a mass-spec identity confirmation, that it is tied to a traceable accession or batch you can look up on the lab’s own site, and that you can read it before checkout rather than after. If any of those is missing, treat the purity number as a marketing claim, not a verified trace. See /how-to-read-peptide-coa for the full walkthrough.

References

1. Goldstein AL, Hannappel E, Kleinman HK. Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol Med. 2005;11(9):421-9. PMID: 16099219. https://pubmed.ncbi.nlm.nih.gov/16099219/
2. Chang CH, Tsai WC, Hsu YH, Pang JH. Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts. Molecules. 2014;19(11):19066-77. PMID: 25415472. https://pubmed.ncbi.nlm.nih.gov/25415472/
3. Cerovecki T, Bojanic I, Brcic L, et al. Pentadecapeptide BPC 157 (PL 14736) improves ligament healing in the rat. J Orthop Res. 2010;28(9):1155-61. PMID: 20225319. https://pubmed.ncbi.nlm.nih.gov/20225319/
4. Philp D, Huff T, Gho YS, Hannappel E, Kleinman HK. The actin binding site on thymosin beta4 promotes angiogenesis. FASEB J. 2003;17(14):2103-5. PMID: 14500546. https://pubmed.ncbi.nlm.nih.gov/14500546/
5. Thymosin Beta-4 and TB-500 in Tissue Healing, Regeneration, and Musculoskeletal Repair: A Scoping Review. Appl Sci. 2026;16(12):6202. https://doi.org/10.3390/app16126202

Full disclosure: coaindex is affiliated with Pepora (peporalabs.com) and earns a commission when you use the coupon above. This is affiliate education, not journalism. We rank vendors on lab-verifiable criteria - named third-party labs, verifiable accessions, HPLC plus mass-spec identity - and we say plainly which SKUs pass and which do not. Everything here concerns research-use-only materials; nothing on this page is for human or veterinary use, and nothing here is medical advice or a dosing protocol.